Endothelial Sash1 Is Required for Lung Maturation through Nitric Oxide Signaling
Patrick Coulombe,
Grigorios N. Paliouras,
Ashley Clayton,
Angela Hussainkhel,
Megan Fuller,
Vida Jovanovic,
Shauna Dauphinee,
Patricia Umlandt,
Ping Xiang,
Alistair H. Kyle,
Andrew I. Minchinton,
R. Keith Humphries,
Pamela A. Hoodless,
Jeremy D.K. Parker,
Joanne L. Wright,
Aly Karsan
Affiliations
Patrick Coulombe
Michael Smith Genome Sciences Centre, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada; Department of Experimental Medicine, University of British Columbia, Vancouver, BC V6T 2B5, Canada
Grigorios N. Paliouras
Michael Smith Genome Sciences Centre, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada
Ashley Clayton
Michael Smith Genome Sciences Centre, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada; Department of Experimental Medicine, University of British Columbia, Vancouver, BC V6T 2B5, Canada
Angela Hussainkhel
Michael Smith Genome Sciences Centre, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada; Program of Interdisciplinary Oncology, University of British Columbia, Vancouver, BC V6T 2B5, Canada
Megan Fuller
Michael Smith Genome Sciences Centre, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada
Vida Jovanovic
Michael Smith Genome Sciences Centre, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada
Shauna Dauphinee
Michael Smith Genome Sciences Centre, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada; Department of Experimental Medicine, University of British Columbia, Vancouver, BC V6T 2B5, Canada
Patricia Umlandt
Michael Smith Genome Sciences Centre, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada
Ping Xiang
Terry Fox Laboratory, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada
Alistair H. Kyle
Department of Integrative Oncology, BC Cancer Research Centre, 675 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada
Andrew I. Minchinton
Department of Integrative Oncology, BC Cancer Research Centre, 675 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada
R. Keith Humphries
Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 2B5, Canada; Terry Fox Laboratory, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada
Pamela A. Hoodless
Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 2B5, Canada; Terry Fox Laboratory, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada
Jeremy D.K. Parker
Michael Smith Genome Sciences Centre, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada
Joanne L. Wright
Department of Pathology, University of British Colombia, Vancouver, BC V6T 2B5, Canada
Aly Karsan
Michael Smith Genome Sciences Centre, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada; Department of Experimental Medicine, University of British Columbia, Vancouver, BC V6T 2B5, Canada; Program of Interdisciplinary Oncology, University of British Columbia, Vancouver, BC V6T 2B5, Canada; Department of Pathology, University of British Colombia, Vancouver, BC V6T 2B5, Canada; Corresponding author
Summary: The sterile alpha motif (SAM) and SRC homology 3 (SH3) domain containing protein 1 (Sash1) acts as a scaffold in TLR4 signaling. We generated Sash1−/− mice, which die in the perinatal period due to respiratory distress. Constitutive or endothelial-restricted Sash1 loss leads to a delay in maturation of alveolar epithelial cells causing reduced surfactant-associated protein synthesis. We show that Sash1 interacts with β-arrestin 1 downstream of the TLR4 pathway to activate Akt and endothelial nitric oxide synthase (eNOS) in microvascular endothelial cells. Generation of nitric oxide downstream of Sash1 in endothelial cells affects alveolar epithelial cells in a cGMP-dependent manner, inducing maturation of alveolar type 1 and 2 cells. Thus, we identify a critical cell nonautonomous function for Sash1 in embryonic development in which endothelial Sash1 regulates alveolar epithelial cell maturation and promotes pulmonary surfactant production through nitric oxide signaling. Lung immaturity is a major cause of respiratory distress and mortality in preterm infants, and these findings identify the endothelium as a potential target for therapy. : Surfactant deficiency due to lung immaturity is a major cause of respiratory distress in premature newborns. Coulombe et al. show that endothelial SAM and SH3 domain containing protein 1 (Sash1) drives perinatal lung maturation via nitric oxide signaling to alveolar cells. Sash1 interacts with β-arrestin1 to activate Akt-eNOS and induce alveolar epithelial cell maturation and surfactant synthesis. Keywords: TLR4, Sash1, surfactant, endothelium, alveolar type 2 cells, respiratory distress, lung development, β-arrestin, nitric oxide